To amend the Public Health Service Act to strike the requirement that the Director of the Centers for Disease Control and Prevention be appointed by and with the advice and consent of the Senate.

H.R. 3820 is a proposal to change how the Director of the Centers for Disease Control and Prevention (CDC) is selected. Under current law passed in 2022, the CDC Director is scheduled to become a Senate-confirmed position starting in January 2025; this bill would repeal that requirement, allowing the President to appoint the Director directly without a Senate vote. For citizens, this change would mean the leadership of the nation’s leading health protection agency is determined solely by the executive branch, potentially speeding up the appointment process during transitions of power while removing the public legislative vetting process used for other high-level federal officials.